While the market and many stocks have showed choppy action, Valeant Pharmaceuticals International (VRX) has continued to make steady progress. The stock is looking at an eighth straight weekly gain and is holding firm near a record high after clearing a 165.79 buy point from a three-weeks-tight pattern. That gives investors a chance to buy shares, if they are confident about the company.